David Bradley Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
David Bradley's research has explored diverse areas, including the medical management of ischemic stroke, the ecological impacts of ocean warming on marine bird populations, and the application of probabilistic prediction in trajectory parameterization. His work also touches on societal considerations of wellbeing and technology, the ethical dimensions of artificial intelligence and privacy, and the conceptualization of EcoMechatronics. Additionally, his interests extend to interstellar polycyclic aromatic hydrocarbons.
With a distinguished scholarly record, Bradley holds an h-index of 48 and has authored 869 publications, accumulating over 9,313 citations. He is recognized as a highly cited researcher and leads a research group at the University of Arkansas at Fayetteville. His recent activity indicates ongoing engagement in scholarly pursuits, with his most recent publication dating to 2025.
Metrics
- h-index: 44
- Publications: 830
- Citations: 7,845
Selected Publications
-
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation (2025)
-
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation (2024)
-
Marine bird mass mortality events as an indicator of the impacts of ocean warming (2023)
-
Artificial Intelligence, Ethics and Privacy (2022)
-
EcoMechatronics: Concepts, Objectives and Outcomes (2022)
-
Sustainable Society: Wellbeing and Technology—3 Case Studies in Decision Making (2022)
-
Interstellar Polycyclic Aromatic Hydrocarbons (2021)
-
Biomaterial approval opens citrate route to medical implants (2021)
-
Temporally-Continuous Probabilistic Prediction using Polynomial Trajectory Parameterization (2021)
Collaboration Network
Top Collaborators
- Sustainable Society: Wellbeing and Technology—3 Case Studies in Decision Making
- Artificial Intelligence, Ethics and Privacy
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
- Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
- Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation
Similar Researchers
Based on overlapping research topics